SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,108 Cr | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,108 Cr |
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,108 Cr | Positive | |
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,296.9 Cr | -1.1% | 0.5% | 34.9% | Stock Analytics | |
| PRIME FOCUS | ₹26,832.7 Cr | 10.9% | 23.5% | 77.4% | Stock Analytics | |
| SAGILITY | ₹21,360.9 Cr | 1.1% | 7.5% | 0.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹14,905.5 Cr | -3.5% | -7% | -42.8% | Stock Analytics | |
| INDEGENE | ₹14,397.8 Cr | 3.4% | 5.9% | 2.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,302.3 Cr | 5.3% | -2.2% | -14.6% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -1.1% |
0.5% |
34.9% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses